Vaccine Immunology
The use of vaccination as a strategy to reduce the impact of disease on society has a long-standing history of success, particularly for viral and bacterial-mediated diseases. The demand for safe and effective vaccine products is increasing due to the potential use of biothreat agents, and the emergence and reemergence of various pathogens. The implementation and use of vaccines in immunologically naive recipients in outbreak settings places extraordinary demands on the timing of the onset of immunity in a relatively broad population base, including those populations which may not always be ideal for delivery of vaccines (e.g., neonates, pregnant women, and the elderly). Each of these populations has its own unique demands for the induction of protective immunity and safety.